share_log

Here's Why We Think Afya (NASDAQ:AFYA) Is Well Worth Watching

Here's Why We Think Afya (NASDAQ:AFYA) Is Well Worth Watching

这就是为什么我们认为Afya(纳斯达克: AFYA)值得关注
Simply Wall St ·  12/02 19:44

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should.

对于新手来说,买入一家向投资者讲述良好故事的公司,即使当前缺乏收入和盈利记录,可能听起来是个好主意(令人兴奋的前景)。但现实情况是,当一家公司每年都亏损足够长的时间时,它的投资者通常会承担这些损失的份额。赤字企业始终在争分夺秒地追求财务可持续性,因此这些企业的投资者可能承担了更多的风险。

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Afya (NASDAQ:AFYA). Now this is not to say that the company presents the best investment opportunity around, but profitability is a key component to success in business.

因此,如果这种高风险高回报的理念不适合您,您可能对像Afya(纳斯达克:AFYA)这样的盈利且增长的公司更感兴趣。这并不是说该公司提供了最佳的投资机会,但盈利能力是业务成功的关键要素。

How Quickly Is Afya Increasing Earnings Per Share?

Afya每股收益增长的速度有多快?

If you believe that markets are even vaguely efficient, then over the long term you'd expect a company's share price to follow its earnings per share (EPS) outcomes. So it makes sense that experienced investors pay close attention to company EPS when undertaking investment research. Impressively, Afya has grown EPS by 37% per year, compound, in the last three years. If the company can sustain that sort of growth, we'd expect shareholders to come away satisfied.

如果您认为市场即使在某种程度上是有效的,那么从长期来看,您会期望一家公司股票的价格跟随其每股收益(EPS)的结果。因此,经验丰富的投资者在进行投资研究时密切关注公司EPS是有道理的。令人印象深刻的是,Afya在过去三年中每股收益复合增长了37%。如果该公司能够维持这种增长,我们预计股东会感到满意。

One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. The music to the ears of Afya shareholders is that EBIT margins have grown from 27% to 29% in the last 12 months and revenues are on an upwards trend as well. Both of which are great metrics to check off for potential growth.

检查公司增长的一种方法是查看其营业收入以及息税前利润(EBIT)利润率的变化。对Afya股东来说好消息是,EBIT利润率在过去12个月中从27%增长到29%,营业收入也在持续上升。这两者都是检查潜在增长的良好指标。

The chart below shows how the company's bottom and top lines have progressed over time. Click on the chart to see the exact numbers.

下面的表格显示了公司的营收和净利润如何随着时间的推移的变化。点击图表可以查看准确的数字。

big
NasdaqGS:AFYA Earnings and Revenue History December 2nd 2024
纳斯达克上市公司:AFYA 收益与营业收入历史 2024年12月2日

You don't drive with your eyes on the rear-view mirror, so you might be more interested in this free report showing analyst forecasts for Afya's future profits.

你不会在开车时盯着后视镜,因此你可能会更感兴趣于这份免费报告,其中展示了分析师对Afya未来利润的预测。

Are Afya Insiders Aligned With All Shareholders?

Afya的内部人士是否与所有股东保持一致?

It should give investors a sense of security owning shares in a company if insiders also own shares, creating a close alignment their interests. Shareholders will be pleased by the fact that insiders own Afya shares worth a considerable sum. Indeed, they have a considerable amount of wealth invested in it, currently valued at R$386m. This totals to 26% of shares in the company. Enough to lead management's decision making process down a path that brings the most benefit to shareholders. So there is opportunity here to invest in a company whose management have tangible incentives to deliver.

如果内部人士也拥有公司的股份,这应该会给投资者一种持有该公司股票的安全感,从而使他们的利益保持紧密一致。股东们会因为内部人士持有价值可观的Afya股份而感到高兴。实际上,他们在该公司投资了大量财富,目前估值为R$38600万。这占公司股份的26%。足以引导管理层的决策过程走上最有利于股东的道路。因此,这里有机会投资于一家管理层拥有实质性激励的公司。

Does Afya Deserve A Spot On Your Watchlist?

Afya值得在你的自选中占有一席之地吗?

You can't deny that Afya has grown its earnings per share at a very impressive rate. That's attractive. This EPS growth rate is something the company should be proud of, and so it's no surprise that insiders are holding on to a considerable chunk of shares. Fast growth and confident insiders should be enough to warrant further research, so it would seem that it's a good stock to follow. Now, you could try to make up your mind on Afya by focusing on just these factors, or you could also consider how its price-to-earnings ratio compares to other companies in its industry.

你无法否认Afya每股收益以非常令人印象深刻的速度增长。这是非常有吸引力的。这个每股收益的增长率是公司应该引以为豪的,因此内部人士持有相当一部分股票也就不足为奇了。快速增长和自信的内部人士应该足以促使进一步研究,因此看起来这是一个值得关注的股票。现在,你可以试着仅仅关注这些因素来决定是否投资Afya,或者你也可以考虑它的市盈率与行业内其他公司的比较。

While opting for stocks without growing earnings and absent insider buying can yield results, for investors valuing these key metrics, here is a carefully selected list of companies in the US with promising growth potential and insider confidence.

尽管不增长收益且没有内部人士购买的股票可能会有回报,但对于重视这些关键指标的投资者来说,以下是在美国具有潜在增长和内部人士信心的经过慎重筛选的公司列表。

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

请注意,本文讨论的内部交易是指在相关司法管辖区中报告的交易。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发